Back to funds
View filing
FCPM III SERVICES B.V.
hedge fundUpdated 27 days agoManaged by Fcpm Iii Services B.V. • Latest filing Q2 2026
Portfolio value
$750.4M
Q2 2026
Filings
11
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
49.9%
Implied from 13F holdings
Portfolio value history
13F-disclosed portfolio value over 11 quarters
Show data table
| Period | Portfolio value |
|---|---|
| Q4 2023 | $339.4M |
| Q1 2024 | $707.3M |
| Q2 2024 | $678.1M |
| Q3 2024 | $582.3M |
| Q4 2024 | $592.4M |
| Q1 2025 | $413.7M |
| Q2 2025 | $369.2M |
| Q3 2025 | $500.4M |
| Q4 2025 | $762.9M |
| Q1 2026 | $722.2M |
| Q2 2026 | $750.4M |
Top holdings
15 positions as of Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | N NAMSW NEWAMSTERDAM PHARMA COMPANY | $157.5M | 4.65M | 20.99% | — |
| 2 | N NAMSW NEWAMSTERDAM PHARMA COMPANY | $130.2M | 3.84M | 17.35% | — |
| 3 | M MPLT MAPLIGHT THERAPEUTICS INC | $115.6M | 3.23M | 15.41% | — |
| 4 | V VOR VOR BIOPHARMA INC | $75.8M | 4.12M | 10.10% | — |
| 5 | ? N/A DAMORA THERAPEUTICS INC | $63.5M | 2.44M | 8.46% | — |
| 6 | D DYN DYNE THERAPEUTICS INC | $53.8M | 2.42M | 7.17% | — |
| 7 | D DYN DYNE THERAPEUTICS INC | $31.7M | 1.43M | 4.22% | — |
| 8 | Q QCOM REPLIMUNE GROUP INC | $31.1M | 2.81M | 4.14% | — |
| 9 | ? N/A CRESCENT BIOPHARMA INC. | $30.2M | 1.68M | 4.02% | — |
| 10 | A AURA AURA BIOSCIENCES INC | $28.8M | 4.05M | 3.84% | — |
| 11 | B BCYC BICYCLE THERAPEUTICS PLC | $14.7M | 3.47M | 1.96% | — |
| 12 | E ENGNW ENGENE HOLDINGS INC | $11.7M | 6.74M | 1.55% | — |
| 13 | E ENGNW ENGENE HOLDINGS INC | $5M | 2.89M | 0.67% | — |
| 14 | E ENGNW ENGENE HOLDINGS INC | $697K | 2.40M | 0.09% | — |
| 15 | E ENGNW ENGENE HOLDINGS INC | $138K | 475.1K | 0.02% | — |